{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:57:34Z","timestamp":1780991854475,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Tianjin Health Research Project","award":["TJWJ2024RC001"],"award-info":[{"award-number":["TJWJ2024RC001"]}]},{"name":"Tianjin Public Health Science and Technology Major Project","award":["24ZXGZSY00030"],"award-info":[{"award-number":["24ZXGZSY00030"]}]},{"name":"Tianjin Key Medical Discipline Construction Project","award":["TJYXZDXK-3-003C"],"award-info":[{"award-number":["TJYXZDXK-3-003C"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10072-026-09112-2","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T03:02:52Z","timestamp":1779505372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ofatumumab therapy modulates the meningeal lymphatic draining function in patients with multiple sclerosis: a pilot study"],"prefix":"10.1007","volume":"47","author":[{"given":"Shu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Wei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Xuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0659-4597","authenticated-orcid":false,"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"key":"9112_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1600-065X.2006.00441.x","volume":"213","author":"MJ Carson","year":"2006","unstructured":"Carson MJ, Doose JM, Melchior B et al (2006) CNS immune privilege: hiding in plain sight. Immunol Rev 213:48\u201365","journal-title":"Immunol Rev"},{"issue":"1","key":"9112_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.it.2006.11.004","volume":"28","author":"I Galea","year":"2007","unstructured":"Galea I, Bechmann I, Perry VH (2007) What is immune privilege (not)? Trends Immunol 28(1):12\u201318","journal-title":"Trends Immunol"},{"issue":"7767","key":"9112_CR3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41586-019-1419-5","volume":"572","author":"JH Ahn","year":"2019","unstructured":"Ahn JH, Cho H, Kim JH et al (2019) Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid. Nature 572(7767):62\u201366","journal-title":"Nature"},{"issue":"12","key":"9112_CR4","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1084\/jem.20170391","volume":"214","author":"S Antila","year":"2017","unstructured":"Antila S, Karaman S, Nurmi H et al (2017) Development and plasticity of meningeal lymphatic vessels. J Exp Med 214(12):3645\u20133667","journal-title":"J Exp Med"},{"issue":"7560","key":"9112_CR5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau A, Smirnov I, Keyes TJ et al (2015) Structural and functional features of central nervous system lymphatic vessels. Nature 523(7560):337\u2013341","journal-title":"Nature"},{"issue":"1","key":"9112_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/ana.25928","volume":"89","author":"CH Wu","year":"2021","unstructured":"Wu CH, Lirng JF, Ling YH et al (2021) Noninvasive Characterization of Human Glymphatics and Meningeal Lymphatics in an in vivo Model of Blood-Brain Barrier Leakage. Ann Neurol 89(1):111\u2013124","journal-title":"Ann Neurol"},{"issue":"10","key":"9112_CR7","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s41593-018-0227-9","volume":"21","author":"A Louveau","year":"2018","unstructured":"Louveau A, Herz J, Alme MN et al (2018) CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat Neurosci 21(10):1380\u20131391","journal-title":"Nat Neurosci"},{"issue":"7717","key":"9112_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41586-018-0368-8","volume":"560","author":"S Da Mesquita","year":"2018","unstructured":"Da Mesquita S, Louveau A, Vaccari A et al (2018) Functional aspects of meningeal lymphatics in ageing and Alzheimer\u2019s disease. Nature 560(7717):185\u2013191","journal-title":"Nature"},{"issue":"3","key":"9112_CR9","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41591-020-01198-1","volume":"27","author":"XB Ding","year":"2021","unstructured":"Ding XB, Wang XX, Xia DH et al (2021) Impaired meningeal lymphatic drainage in patients with idiopathic Parkinson\u2019s disease. Nat Med 27(3):411\u2013418","journal-title":"Nat Med"},{"key":"9112_CR10","doi-asserted-by":"crossref","unstructured":"Wang M, Ran L, Liu B et al (2023) Disturbed meningeal lymphatic function associated with malignancy and progression in patients with intracranial malignant tumors. Med (New York, N.Y.) 4(12):898-912.e894","DOI":"10.1016\/j.medj.2023.10.001"},{"key":"9112_CR11","doi-asserted-by":"publisher","first-page":"692051","DOI":"10.3389\/fimmu.2021.692051","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, Tian H, Liu H et al (2021) Impaired Meningeal Lymphatic Flow in NMOSD Patients With Acute Attack. Front Immunol 12:692051","journal-title":"Front Immunol"},{"issue":"3","key":"9112_CR12","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/ana.26842","volume":"95","author":"CH Wu","year":"2024","unstructured":"Wu CH, Chang FC, Wang YF et al (2024) Impaired Glymphatic and Meningeal Lymphatic Functions in Patients with Chronic Migraine. Ann Neurol 95(3):583\u2013595","journal-title":"Ann Neurol"},{"issue":"9648","key":"9112_CR13","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A (2008) Multiple sclerosis. Lancet (London England) 372(9648):1502\u20131517","journal-title":"Lancet (London England)"},{"issue":"2","key":"9112_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMra1401483","volume":"378","author":"DS Reich","year":"2018","unstructured":"Reich DS, Lucchinetti CF, Calabresi PA (2018) Multiple Sclerosis. N Engl J Med 378(2):169\u2013180","journal-title":"N Engl J Med"},{"issue":"20","key":"9112_CR15","doi-asserted-by":"publisher","first-page":"e1805","DOI":"10.1212\/WNL.0000000000005516","volume":"90","author":"A Bar-Or","year":"2018","unstructured":"Bar-Or A, Grove RA, Austin DJ et al (2018) Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study. Neurology 90(20):e1805\u2013e1814","journal-title":"Neurology"},{"issue":"6","key":"9112_CR16","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1056\/NEJMoa1917246","volume":"383","author":"SL Hauser","year":"2020","unstructured":"Hauser SL, Bar-Or A, Cohen JA et al (2020) Ofatumumab versus Teriflunomide in Multiple Sclerosis. N Engl J Med 383(6):546\u2013557","journal-title":"N Engl J Med"},{"issue":"3","key":"9112_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJMoa1606468","volume":"376","author":"X Montalban","year":"2017","unstructured":"Montalban X, Hauser SL, Kappos L et al (2017) Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis. N Engl J Med 376(3):209\u2013220","journal-title":"N Engl J Med"},{"issue":"8","key":"9112_CR18","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1056\/NEJMoa2201904","volume":"387","author":"L Steinman","year":"2022","unstructured":"Steinman L, Fox E, Hartung HP et al (2022) Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis. N Engl J Med 387(8):704\u2013714","journal-title":"N Engl J Med"},{"key":"9112_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/B978-0-444-52001-2.00004-2","volume":"122","author":"C Lubetzki","year":"2014","unstructured":"Lubetzki C, Stankoff B (2014) Demyelination in multiple sclerosis. Handb Clin Neurol 122:89\u201399","journal-title":"Handb Clin Neurol"},{"issue":"Pt 2","key":"9112_CR20","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/brain\/awq350","volume":"134","author":"L Lovato","year":"2011","unstructured":"Lovato L, Willis SN, Rodig SJ et al (2011) Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis. Brain 134(Pt 2):534\u2013541","journal-title":"Brain"},{"issue":"7","key":"9112_CR21","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1093\/brain\/awy151","volume":"141","author":"J Machado-Santos","year":"2018","unstructured":"Machado-Santos J, Saji E, Tr\u00f6scher AR et al (2018) The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8\u2009+\u2009T lymphocytes and B cells. Brain 141(7):2066\u20132082","journal-title":"Brain"},{"issue":"Pt 9","key":"9112_CR22","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1093\/brain\/awr182","volume":"134","author":"OW Howell","year":"2011","unstructured":"Howell OW, Reeves CA, Nicholas R et al (2011) Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain 134(Pt 9):2755\u20132771","journal-title":"Brain"},{"issue":"23","key":"9112_CR23","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1056\/NEJMoa1100648","volume":"365","author":"CF Lucchinetti","year":"2011","unstructured":"Lucchinetti CF, Popescu BF, Bunyan RF et al (2011) Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 365(23):2188\u20132197","journal-title":"N Engl J Med"},{"issue":"Pt 4","key":"9112_CR24","first-page":"1089","volume":"130","author":"R Magliozzi","year":"2007","unstructured":"Magliozzi R, Howell O, Vora A et al (2007) Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130(Pt 4):1089\u20131104","journal-title":"Brain"},{"issue":"4","key":"9112_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/ana.22230","volume":"68","author":"R Magliozzi","year":"2010","unstructured":"Magliozzi R, Howell OW, Reeves C et al (2010) A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol 68(4):477\u2013493","journal-title":"Ann Neurol"},{"key":"9112_CR26","doi-asserted-by":"crossref","unstructured":"Yang S, Zhang TX, Liu J et al (2025) Reconstitution of CXCR3(+) CCR6(+) Th17.1-Like T cells in response to ofatumumab therapy in patients with multiple sclerosis. Ann Clin Transl Neurol 12(5):1043\u20131053.","DOI":"10.1002\/acn3.70042"},{"issue":"7","key":"9112_CR27","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1177\/13524585211049397","volume":"28","author":"Z Weinstock","year":"2022","unstructured":"Weinstock Z, Morrow S, Conway D et al (2022) Interpreting change on the Symbol Digit Modalities Test in people with relapsing multiple sclerosis using the reliable change methodology. Mult Scler 28(7):1101\u20131111","journal-title":"Mult Scler"},{"issue":"1","key":"9112_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1177\/1352458516638941","volume":"23","author":"D Cadavid","year":"2017","unstructured":"Cadavid D, Cohen JA, Freedman MS et al (2017) The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis. Mult Scler 23(1):94\u2013105","journal-title":"Mult Scler"},{"issue":"Pt 11","key":"9112_CR29","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1093\/brain\/awh641","volume":"128","author":"A Kutzelnigg","year":"2005","unstructured":"Kutzelnigg A, Lucchinetti CF, Stadelmann C et al (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128(Pt 11):2705\u20132712","journal-title":"Brain"},{"key":"9112_CR30","doi-asserted-by":"crossref","unstructured":"Brand RM, Friedrich V, Diddens J et al (2021) Anti-CD20 depletes meningeal B cells but does not halt the formation of meningeal ectopic lymphoid tissue. Neurology(R) Neuroimmunol Neuroinflamm 8(4):e1012","DOI":"10.1212\/NXI.0000000000001012"},{"key":"9112_CR31","doi-asserted-by":"crossref","unstructured":"Roodselaar J, Zhou Y, Leppert D et al (2021) Anti-CD20 disrupts meningeal B-cell aggregates in a model of secondary progressive multiple sclerosis. Neurology(R) Neuroimmunol Neuroinflamm 8(3):e975","DOI":"10.1212\/NXI.0000000000000975"},{"issue":"8","key":"9112_CR32","doi-asserted-by":"publisher","first-page":"e71058","DOI":"10.1371\/journal.pone.0071058","volume":"8","author":"A Achiron","year":"2013","unstructured":"Achiron A, Chapman J, Magalashvili D et al (2013) Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study. PLoS ONE 8(8):e71058","journal-title":"PLoS ONE"},{"issue":"2","key":"9112_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/WNN.0000000000000097","volume":"29","author":"N Korakas","year":"2016","unstructured":"Korakas N, Tsolaki M (2016) Cognitive Impairment in Multiple Sclerosis: A Review of Neuropsychological Assessments. Cogn Behav neurology: official J Soc Behav Cogn Neurol 29(2):55\u201367","journal-title":"Cogn Behav neurology: official J Soc Behav Cogn Neurol"},{"issue":"10","key":"9112_CR34","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/S1474-4422(18)30309-0","volume":"17","author":"MA Rocca","year":"2018","unstructured":"Rocca MA, Barkhof F, De Luca J et al (2018) The hippocampus in multiple sclerosis. Lancet Neurol 17(10):918\u2013926","journal-title":"Lancet Neurol"},{"issue":"4","key":"9112_CR35","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.neuroimage.2007.04.017","volume":"36","author":"A Tekok-Kilic","year":"2007","unstructured":"Tekok-Kilic A, Benedict RH, Weinstock-Guttman B et al (2007) Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis. NeuroImage 36(4):1294\u20131300","journal-title":"NeuroImage"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09112-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09112-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09112-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:05:42Z","timestamp":1780988742000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09112-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["9112"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09112-2","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Th study was approved by the Ethics Committee at Tianjin Medical University General Hospital (IRB2002-YX-056-01) and registered at ClinicalTrials.gov (OMNISCIENCE study, NCT05414487).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical"}},{"value":"Shu Yang, Xiu-Wei Fu, Zhi-Xuan Liu, Lijie Zhu, Jia Liu, Zhirui Liu, Tian-Xiang Zhang, Si-Qi Wang and Bin Feng, Jun-Ping Wang and Chao Zhang declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"515"}}